Journal of Pharmacological Sciences · 2009 · 17 citations · 9 references
Life SciencesNeuroscienceNutritional SciencesCognitive NeuroscienceMolecular NeuroscienceNeurodegenerationAlzheimer DiseaseAmyloid FormationCognitive ImpairmentGrowth HormoneNeurodegenerative DiseasesNeurodegenerative DisordersAmyloid Beta PathwaysGrowth Hormone SignalingInsulin-like Growth Factor 1 DeficiencyInsulin-like Growth Factor DeficiencyInsulin-like Growth Factor-1Insulin-like Growth FactorsNutrition In Alzheimer's Disease
We previously demonstrated that the growth hormone (GH)-releaser diet ameliorated beta-amyloid (A beta) (1-42)-induced memory impairment, but the underlying mechanism remained to be characterized. We show here that the GH-releaser diet significantly attenuated A beta(1-42)-induced impairment in context-dependent conditioned fear, with a reduction in GH levels and changes in hippocampal acetylcholine, acetylcholinesterase, choline acetyltransferase, insulin-like growth factor (IGF)-1, and IGF-1-receptor activity in mice. JB-1, an IGF-1-receptor antagonist, significantly blocked GH-releaser diet-mediated pharmacological actions. Our results suggest that the GH-releaser diet prevents A beta(1-42)-induced cognitive deficits via stimulation of the hippocampal IGF-1 receptor.
9
Permeation of Growth Hormone across the Blood-Brain Barrier
Weihong Pan, Yongmei Yu, Courtney Cain et al. · Endocrinology · 2005 · 148 citations
Medicine, Endocrinology, Physiology +17
Manh Hung Tran, Kiyofumi Yamada, Ana Olariu et al. · The FASEB Journal · 2001 · 98 citations